AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8835616 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (80 micrograms/kg/s.c., three times a day)
Number of subjects: 34
Study 8835616 — intervention group
Group type: COMPARATOR
Intervention: Saline (0.9% NaCl)
Number of subjects: 34
Study 2109497 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant with predominant serotoninergic action (indalpine or citalopram)
Number of subjects: 100
Study 2109497 — intervention group
Group type: EXPERIMENTAL
Intervention: Noradrenergic antidepressant (maprotiline)
Number of subjects: 100
Study 2109497 — intervention group
Group type: COMPARATOR
Intervention: TRH test
Number of subjects: 100
Study 7438751 — intervention group
Group type: EXPERIMENTAL
Intervention: Reversible tubal sterilization
Number of subjects: 1074
Study 31291314 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group with access to different bike types (e-bike with trailer, cargo bike, traditional bike with trailer)
Number of subjects: 36
Study 31291314 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 36
Study 29323626 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT-based mobile-app program (Todac Todac)
Number of subjects: 34
Study 29323626 — intervention group
Group type: COMPARATOR
Intervention: Daily mood chart app program (control group)
Number of subjects: 34
Study 29323626 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (TT group and control group)
Number of subjects: 34
Study 27454011 — intervention group
Group type: EXPERIMENTAL
Intervention: Recall manipulation of preoccupying secrets
Number of subjects: 3000
Study 27454011 — intervention group
Group type: EXPERIMENTAL
Intervention: Recall manipulation of extreme exemplar secrets
Number of subjects: 3000
Study 25019632 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation (Tele)
Number of subjects: 24
Study 25019632 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (Conv)
Number of subjects: 24
Study 22670591 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional HUT (20-minute passive tilt followed by 25 minutes after administration of sublingual isosorbide dinitrate)
Number of subjects: 60
Study 22670591 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortened HUT (ISDN given immediately after tilt and observed for 25 minutes)
Number of subjects: 60
Study 22670591 — intervention group
Group type: COMPARATOR
Intervention: Control group (age- and gender-matched subjects without VVS symptoms)
Number of subjects: 60
Study 20633872 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal endometriosis group
Number of subjects: 300
Study 20633872 — intervention group
Group type: COMPARATOR
Intervention: Control group (women without endometriosis)
Number of subjects: 300
Study 18336919 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR) - 5 sessions
Number of subjects: 20
Study 16150195 — intervention group
Group type: EXPERIMENTAL
Intervention: Yigu capsule (YGC)
Number of subjects: 210
Study 16150195 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 16150195 — intervention group
Group type: COMPARATOR
Intervention: Calciferol
Number of subjects: 210
Study 11124354 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-word primes differing by a single phonemic feature (e.g. ZEA, VILM, PASIC)
Number of subjects: 0
Study 11124354 — intervention group
Group type: COMPARATOR
Intervention: Non-word primes differing by more than a single phonemic feature (e.g. VEA, JILM, SASIC)
Number of subjects: 0
Study 9849010 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (CT) alone
Number of subjects: 39
Study 9849010 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemo-radiotherapy (CT + RT)
Number of subjects: 39
Study 9849010 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone
Number of subjects: 39
Study 8010424 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive learning system with 'sensorized' manikin head
Number of subjects: 97
Study 8010424 — intervention group
Group type: COMPARATOR
Intervention: Didactic instruction from anesthesiologists
Number of subjects: 97
Study 2589071 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 20
Study 2589071 — intervention group
Group type: COMPARATOR
Intervention: Injected anaesthetic
Number of subjects: 20
Study 1059213 — intervention group
Group type: EXPERIMENTAL
Intervention: Male subjects with male audience
Number of subjects: 48
Study 1059213 — intervention group
Group type: EXPERIMENTAL
Intervention: Male subjects with female audience
Number of subjects: 48
Study 1059213 — intervention group
Group type: EXPERIMENTAL
Intervention: Female subjects with male audience
Number of subjects: 48
Study 1059213 — intervention group
Group type: EXPERIMENTAL
Intervention: Female subjects with female audience
Number of subjects: 48
Study 31377711 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Appointments in Primary Care (GAP) intervention
Number of subjects: 15
Study 28139220 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-Eluting Balloons (DEB) for DES-ISR
Number of subjects: 249
Study 28139220 — intervention group
Group type: COMPARATOR
Intervention: Drug-Eluting Balloons (DEB) for BMS-ISR
Number of subjects: 249
Study 26119968 — intervention group
Group type: COMPARATOR
Intervention: Accumulated million steps group (AMSG)
Number of subjects: 120
Study 26119968 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise group (AEG)
Number of subjects: 120
Study 23557553 — intervention group
Group type: EXPERIMENTAL
Intervention: Double kissing (DK) crush technique
Number of subjects: 61
Study 23557553 — intervention group
Group type: COMPARATOR
Intervention: Classical crush technique
Number of subjects: 61
Study 23557553 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-procedural minimum stent area (MSA)
Number of subjects: 61
Study 21682869 — intervention group
Group type: EXPERIMENTAL
Intervention: Organized exercise training three times per week starting in gestation week 14 (range 12‐16)
Number of subjects: 150
Study 21682869 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 150
Study 20092180 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery preceded by studying haemostasiograms, biochemical parameters, indices of the functional system of detoxication, level of acute-phase proteins, cytokines, stress enzymes.
Number of subjects: 34
Study 20092180 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 34
Study 16629894 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% sodium hypochlorite (NaOCl)
Number of subjects: 13
Study 16629894 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzymatic commercial solution (Ortoform)
Number of subjects: 13
Study 16629894 — intervention group
Group type: COMPARATOR
Intervention: Negative control
Number of subjects: 13
Study 14769738 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (50 mg/d)
Number of subjects: 29133
Study 14769738 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (20 mg/d)
Number of subjects: 29133
Study 14769738 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 29133
Study 11411816 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone treatment
Number of subjects: 37
Study 9582179 — intervention group
Group type: EXPERIMENTAL
Intervention: NeuroSPECT findings in anosmic patients
Number of subjects: 18
Study 9582179 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 18
Study 7996624 — intervention group
Group type: EXPERIMENTAL
Intervention: Rinne test (unmasked and masked)
Number of subjects: 68
Study 7996624 — intervention group
Group type: EXPERIMENTAL
Intervention: Weber test
Number of subjects: 68
Study 7996624 — intervention group
Group type: EXPERIMENTAL
Intervention: Bing test
Number of subjects: 68
Study 7996624 — intervention group
Group type: EXPERIMENTAL
Intervention: Rinne test (without masking)
Number of subjects: 68
Study 7996624 — intervention group
Group type: COMPARATOR
Intervention: Normal hearing (control group)
Number of subjects: 68
Study 3255892 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine
Number of subjects: 0
Study 3255892 — intervention group
Group type: EXPERIMENTAL
Intervention: Trihexyphenidyl
Number of subjects: 0
Study 3255892 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0
Study 3255892 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 0
Study 31888751 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumen-apposing metal stents (LAMS)
Number of subjects: 114
Study 31888751 — intervention group
Group type: COMPARATOR
Intervention: Plastic stents
Number of subjects: 114
Study 28954841 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-biofortified beans (86.1 ppm iron)
Number of subjects: 150
Study 28954841 — intervention group
Group type: COMPARATOR
Intervention: Control beans (50.1 ppm iron)
Number of subjects: 150
Study 26122296 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic OC users
Number of subjects: 377
Study 26122296 — intervention group
Group type: EXPERIMENTAL
Intervention: NC women
Number of subjects: 377
Study 26122296 — intervention group
Group type: COMPARATOR
Intervention: Men
Number of subjects: 377
Study 26122296 — intervention group
Group type: COMPARATOR
Intervention: OC users (heterogeneous group)
Number of subjects: 377
Study 26122296 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol levels in OC users
Number of subjects: 377
Study 23548260 — intervention group
Group type: EXPERIMENTAL
Intervention: Solifenacin succinate (SS)
Number of subjects: 40
Study 23548260 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous tibial nerve stimulation (PTNS)
Number of subjects: 40
Study 22032052 — intervention group
Group type: EXPERIMENTAL
Intervention: DDDR pacing mode
Number of subjects: 67
Study 22032052 — intervention group
Group type: COMPARATOR
Intervention: WIR pacing mode
Number of subjects: 67
Study 18293201 — intervention group
Group type: EXPERIMENTAL
Intervention: MgSO(4) continuous infusion for 24 hours postpartum (Group A)
Number of subjects: 50
Study 18293201 — intervention group
Group type: COMPARATOR
Intervention: MgSO(4) administration discontinued when urinary output was > or =100 ml/hr for 2 consecutive hours (Group B)
Number of subjects: 50
Study 18293201 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 50
Study 17069813 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic proximal tubal occlusion
Number of subjects: 115
Study 17069813 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic salpingectomy
Number of subjects: 115
Study 17069813 — intervention group
Group type: COMPARATOR
Intervention: No surgical intervention
Number of subjects: 115
Study 12233987 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 2
Study 10194084 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether
Number of subjects: 9
Study 10194084 — intervention group
Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 9
Study 7761293 — intervention group
Group type: EXPERIMENTAL
Intervention: ComputerLink
Number of subjects: 102
Study 2405896 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil i.v. and placebo s.c. (group A)
Number of subjects: 30
Study 2405896 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil i.v. and flumazenil s.c. (group B)
Number of subjects: 30
Study 2405896 — intervention group
Group type: COMPARATOR
Intervention: Placebo i.v. and placebo s.c. (control group)
Number of subjects: 30
Study 7415857 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous femoral artery catheterization
Number of subjects: 0
Study 7415857 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 6342959 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole suppositories (short-term use for 72 hours)
Number of subjects: 133
Study 6342959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study 31238713 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 13885
Study 31238713 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 13885
Study 31238713 — intervention group
Group type: EXPERIMENTAL
Intervention: Any previous peripheral revascularization
Number of subjects: 13885
Study 31238713 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline atrial fibrillation
Number of subjects: 13885
Study 31238713 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline ankle-brachial index =0.60
Number of subjects: 13885
Study 31238713 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 13885
Study 31238713 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline statin use
Number of subjects: 13885
Study 31238713 — intervention group
Group type: EXPERIMENTAL
Intervention: ALI hospitalization
Number of subjects: 13885
Study 28952862 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week, 12-session feedback intervention including self-analysis and expert feedback on jump-landing mechanics
Number of subjects: 0
Study 26833642 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 2737
Study 26833642 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 2737
Study 25191896 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact whey protein (IW)
Number of subjects: 24
Study 25191896 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolysed casein (HC)
Number of subjects: 24
Study 25191896 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact casein (IC)
Number of subjects: 24
Study 22834921 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone and ketamine (MK)
Number of subjects: 22
Study 22834921 — intervention group
Group type: COMPARATOR
Intervention: Methadone alone (ME)
Number of subjects: 22
Study 21164546 — intervention group
Group type: EXPERIMENTAL
Intervention: β‐glucan (100 mg, Imunoglukan) supplementation
Number of subjects: 20
Study 21164546 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 20
Study 17825546 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 and omega-6 polyunsaturated fatty acids (PUFA) supplementation
Number of subjects: 104
Study 17825546 — intervention group
Group type: COMPARATOR
Intervention: Placebo (palm oil)
Number of subjects: 104
Study 17825546 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PUFA and placebo groups
Number of subjects: 104
Study 16126134 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue plasminogen activator
Number of subjects: 624
Study 16126134 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 624
Study 12269944 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin prick testing (SPT) and food-specific IgE assessment for potential cross-reactive foods
Number of subjects: 65
Study 12269944 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine challenges with potential cross-reactive foods
Number of subjects: 65
Study 12269944 — intervention group
Group type: EXPERIMENTAL
Intervention: SPT and food-specific IgE levels for potential cross-reactive foods
Number of subjects: 65
Study 12269944 — intervention group
Group type: EXPERIMENTAL
Intervention: Elimination diets based on allergy testing
Number of subjects: 65
Study 10024253 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor exercises (n=25)
Number of subjects: 107
Study 10024253 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation (n=25)
Number of subjects: 107
Study 10024253 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal cones (n=27)
Number of subjects: 107
Study 10024253 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=30)
Number of subjects: 107
Study 7845115 — intervention group
Group type: EXPERIMENTAL
Intervention: Single course of portal infusion with mitomycin (10 mg/m2, one dose) plus fluorouracil (500 mg/m2 per 24 h for 7 days)
Number of subjects: 533
Study 7845115 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant treatment
Number of subjects: 533
Study 2140842 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright white light therapy (2500 lux)
Number of subjects: 30
Study 2140842 — intervention group
Group type: COMPARATOR
Intervention: Dim light therapy (50 lux)
Number of subjects: 30
Study 572195 — intervention group
Group type: EXPERIMENTAL
Intervention: Piloplex (11 b.i.d.)
Number of subjects: 51
Study 572195 — intervention group
Group type: COMPARATOR
Intervention: Pilocarpine hydrochloride 2% q.i.d.
Number of subjects: 51
Study 30572281 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided platelet-rich plasma (PRP) injection
Number of subjects: 36
Study 30572281 — intervention group
Group type: COMPARATOR
Intervention: Platelet-poor plasma (PPP) injection
Number of subjects: 36
Study 27878381 — intervention group
Group type: EXPERIMENTAL
Intervention: S-ICD®
Number of subjects: 120
Study 27878381 — intervention group
Group type: COMPARATOR
Intervention: tv-ICD
Number of subjects: 120
Study 25894865 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenomethionine (SeMet) 200 μg daily (n = 28)
Number of subjects: 55
Study 25894865 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 27)
Number of subjects: 55
Study 23344509 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg per os divided in two doses (night before surgery and 1 h preoperatively)
Number of subjects: 50
Study 23344509 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 23344509 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg per os divided in two doses
Number of subjects: 50
Study 21429799 — intervention group
Group type: EXPERIMENTAL
Intervention: Motesanib plus paclitaxel
Number of subjects: 282
Study 21429799 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus paclitaxel
Number of subjects: 282
Study 21429799 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus paclitaxel
Number of subjects: 282
Study 21429799 — intervention group
Group type: EXPERIMENTAL
Intervention: Motesanib
Number of subjects: 282
Study 21429799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282
Study 21429799 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 282
Study 19646212 — intervention group
Group type: EXPERIMENTAL
Intervention: MSP3-LSP candidate vaccine
Number of subjects: 30
Study 19646212 — intervention group
Group type: COMPARATOR
Intervention: Tetanus toxoid vaccine (Control)
Number of subjects: 30
Study 17376305 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with terazosin 2 mg once daily and tolterodine 2 mg twice daily for 6 weeks
Number of subjects: 69
Study 17376305 — intervention group
Group type: COMPARATOR
Intervention: Terazosin 2 mg once daily for 6 weeks
Number of subjects: 69
Study 15264729 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalloid coload (20 ml x kg(‐1) of crystalloid solution by rapid infusion immediately after induction)
Number of subjects: 50
Study 15264729 — intervention group
Group type: COMPARATOR
Intervention: Crystalloid preload (20 ml x kg(‐1) of crystalloid solution during 20 minutes prior to induction)
Number of subjects: 50
Study 15264729 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalloid preload and coload
Number of subjects: 50
Study 12188588 — intervention group
Group type: EXPERIMENTAL
Intervention: Active bupropion
Number of subjects: 784
Study 12188588 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 784
Study 10786491 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated Peritoneal Dialysis (APD) with large fill volumes and an extra daytime exchange
Number of subjects: 0
Study 10786491 — intervention group
Group type: COMPARATOR
Intervention: Conventional CAPD methods
Number of subjects: 0
Study 8787251 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion during cardiopulmonary bypass (CPB)
Number of subjects: 20
Study 8787251 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (control)
Number of subjects: 20
Study 8787251 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion during CPB
Number of subjects: 20
Study 2108981 — intervention group
Group type: EXPERIMENTAL
Intervention: buserelin (Suprefact, Hoechst, UK, Ltd, Hounslow, Middlesex), 800 micrograms/day by nasal insufflation
Number of subjects: 46
Study 2108981 — intervention group
Group type: EXPERIMENTAL
Intervention: pure follicle stimulating hormone (FSH)
Number of subjects: 46
Study 2108981 — intervention group
Group type: COMPARATOR
Intervention: human menopausal gonadotrophin (HMG)
Number of subjects: 46
Study 7000232 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxprenolol 40 mg
Number of subjects: 0
Study 7000232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30829017 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant drug use in PES group (n=3, 4.1%)
Number of subjects: 2009
Study 30829017 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant drug use in non-PES non-glaucoma group (n=21, 1.1%)
Number of subjects: 2009
Study 30829017 — intervention group
Group type: EXPERIMENTAL
Intervention: Medications for hypertension in PES group
Number of subjects: 2009
Study 30829017 — intervention group
Group type: EXPERIMENTAL
Intervention: Medications for coronary artery disease in PES group
Number of subjects: 2009
Study 29031582 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's Eating Behavior Questionnaire (CEBQ) subscale: food responsiveness
Number of subjects: 295
Study 29031582 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's Eating Behavior Questionnaire (CEBQ) subscale: slowness in eating
Number of subjects: 295
Study 29031582 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's Eating Behavior Questionnaire (CEBQ) subscale: satiety responsiveness
Number of subjects: 295
Study 27428294 — intervention group
Group type: EXPERIMENTAL
Intervention: Concord grape juice (CGJ)
Number of subjects: 26
Study 27428294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 24460655 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferasirox (9.7 ± 3.0 mg/kg/d)
Number of subjects: 24
Study 24460655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 22122781 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenolization with curettage
Number of subjects: 51
Study 22122781 — intervention group
Group type: COMPARATOR
Intervention: Phenolization alone
Number of subjects: 51